Nursing Diagnosis for Pneumonia: Key Considerations

NANDA nursing diagnoses follow the PES format: Problem (the nursing diagnosis label) + Etiology (related to / R/T) + Signs and Symptoms (as evidenced by / AEB). This format converts the clinical assessment into a precise, actionable statement that drives care planning. Example: Ineffective Airway Clearance related to increased mucus production and inflamed airways secondary to pneumonia, as evidenced by productive cough with thick yellow sputum, audible crackles on auscultation of the right lower lobe, respiratory rate 26/min, and SpO2 93% on room air. Breaking down each element: Problem: 'Ineffective Airway Clearance' (NANDA-I code 00031) — this tells the team exactly what the nursing problem is. Related to: 'increased mucus production and airway inflammation' — the mechanism; this drives which interventions you choose (secretion-clearance techniques, hydration, nebulised saline). As evidenced by: objective findings from assessment — the crackles, RR, SpO2, and sputum characteristics; these become the outcome benchmarks (i.e., care is working when crackles clear, RR normalises, sputum thins). Additional NANDA diagnoses for pneumonia with their R/T examples: Impaired Gas Exchange R/T alveolar-capillary membrane damage and fluid accumulation AEB PaO2 58 mmHg on ABG, confusion, cyanosis; Hyperthermia R/T infectious process AEB temperature 39.4°C, diaphoresis, flushed skin; Acute Pain R/T pleuritic inflammation AEB patient-reported 7/10 chest pain worsening on deep breath, guarded breathing. A well-written PES statement should allow any nurse covering the patient to understand exactly what problem exists, why it exists, and how to measure improvement — without needing to read the full notes.

These two diagnoses address different parts of the respiratory failure pathway in pneumonia and are often present simultaneously but require distinct interventions. Ineffective Airway Clearance (NANDA 00031): the problem is in the airway — excess mucus, inability to cough effectively, or airway narrowing from bronchospasm. The patient can oxygenate adequately if the airway is clear; the obstruction prevents this. Defining characteristics: productive or non-productive cough, abnormal breath sounds (crackles, rhonchi — low-pitched sounds from secretions in large airways), difficulty expectorating, changes in respiratory rate/rhythm. Etiology in pneumonia: infection-driven mucus hypersecretion, pain limiting effective cough effort, weakness/fatigue. Interventions: controlled coughing and huffing technique, incentive spirometry, positioning (Fowler's/side-lying), adequate hydration (2–2.5 L/day thins secretions), nebulised normal saline, chest physiotherapy, suction if unable to clear independently. Impaired Gas Exchange (NANDA 00030): the problem is in the alveoli — fluid flooding the air sacs so that oxygen cannot cross the membrane into the bloodstream, even if the airway above is clear. Defining characteristics: hypoxaemia on ABG (low PaO2, low SaO2), restlessness or confusion (brain hypoxia), cyanosis, abnormal ABG CO2 levels, SpO2 below target on room air. Etiology in pneumonia: alveolar consolidation from exudate, V/Q mismatch. Interventions: supplemental oxygen (titrate to target SpO2 92–96%), positioning to optimise V/Q (prone positioning or high Fowler's, good-lung-down positioning for unilateral consolidation), continuous SpO2 monitoring, escalation to CPAP/BiPAP if O2 requirements increase beyond 6 LPM simple mask. The practical distinction: if giving oxygen improves SpO2 and removing secretions reduces rhonchi, both problems coexist; if SpO2 doesn't improve despite patent airway, Impaired Gas Exchange is the dominant problem requiring escalation.

Activity Intolerance in pneumonia (NANDA 00092) stems from several converging factors: increased metabolic demand from fever and infection, reduced oxygen delivery (hypoxaemia), respiratory muscle fatigue from the increased work of breathing, and deconditioning from bed rest — which itself reduces functional capacity by approximately 1–2% per day of bed rest. The nursing goal is to begin mobilisation as soon as physiologically tolerated, because prolonged bed rest worsens atelectasis, increases DVT risk, and delays functional recovery. Progressive mobilisation protocol: Day 1 (if SpO2 ≥92% on ≤4 LPM O2 and RR <28): dangle at the side of the bed for 5–10 minutes with assistance. Monitor SpO2 and RR during and after — if SpO2 drops >4% or RR increases >6/min, return to bed, wait 30 minutes, and reassess. Day 2–3: chair transfers with assistance, sitting out of bed for meals. Day 3–4: short walks (5–10 metres) with nursing escort and portable SpO2 monitoring. Day 4+: increasing distance based on tolerance, aiming for self-care activities (washing, dressing) before discharge. SMART outcome criteria for Activity Intolerance resolution: 'Patient will tolerate 15 metres of ambulation at self-selected pace with no SpO2 drop below 92% and dyspnoea score ≤3/10 on Borg scale by day 4 of admission.' Barriers to mobilisation in India: underutilisation of physiotherapy on medical wards, families who interpret bed rest as 'proper rest'; nursing's role includes explicitly communicating to families why early walking is therapeutic, not negligent. Document each mobilisation attempt with distance, SpO2 before/during/after, Borg scale, and any adverse events.

Each NANDA nursing diagnosis needs measurable, time-bound outcome criteria (NOC — Nursing Outcomes Classification) that the nurse can objectively assess. Here are the resolution criteria for the key pneumonia diagnoses: Ineffective Airway Clearance is resolved when: breath sounds are clear to auscultation bilaterally (or crackles markedly reduced), patient demonstrates effective cough with expectoration of thinned secretions, RR is 12–20/min at rest, SpO2 ≥92% on prescribed O2. Target: 48–72 hours post-admission with appropriate antibiotics and airway management. Impaired Gas Exchange is resolved when: SpO2 ≥92% on room air (or pre-admission baseline), ABG PaO2 >60 mmHg (if monitored), absence of cyanosis, patient alert and oriented (if confusion was due to hypoxia), minimal supplemental O2 requirement. Target: 3–5 days post-admission depending on severity; CXR may lag behind clinical improvement by 1–2 weeks and should not be used as the sole discharge criterion. Hyperthermia is resolved when: temperature <37.8°C for ≥24 hours without antipyretics, diaphoresis resolved, patient comfortable. Acute Pain (pleuritic) is resolved when: pain score ≤2/10, patient demonstrates full deep breathing without guarding, able to cough effectively. Activity Intolerance is resolved when: patient tolerates self-care activities and required ambulation distance without significant SpO2 drop or dyspnoea. Evaluation process: reassess each diagnosis at every shift, document objective findings against these criteria, and — critically — escalate to the treating team if a diagnosis is not resolving within expected timeframes. Non-resolving Ineffective Airway Clearance at 72 hours despite treatment should prompt a review of antibiotic coverage, sputum culture results, and CXR for complications (pleural effusion, abscess).